Association between CYP2C19 genotype and the additional effect of cilostazol to clopidogrel resistance in neuroendovascular therapy

We investigated the association between CYP2C19 genotype and additional effect of cilostazol on clopidogrel resistance (CR) in neuroendovascular therapy. Between January 2012 and January 2016, 447 consecutive patients were administered with 75-mg cilostazol/day. The VerifyNow System was used for eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajima, Hayato, Izumi, Takashi, Miyachi, Shigeru, Matsubara, Noriaki, Ito, Masashi, Imai, Tasuku, Nishihori, Masahiro, Shintai, Kazunori, Okamoto, Sho, Araki, Yoshio, Kumakura, Yasuo, Furukawa-Hibi, Yoko, Yamada, Kiyofumi, Wakabayashi, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995740/
https://www.ncbi.nlm.nih.gov/pubmed/29915438
http://dx.doi.org/10.18999/nagjms.80.2.207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995740/
https://www.ncbi.nlm.nih.gov/pubmed/29915438
http://dx.doi.org/10.18999/nagjms.80.2.207

Ejemplares similares